Paris-based Exeliom Biosciences, a clinical-stage BioTech company developing new therapies in immuno-oncology and immuno-inflammation, today announced the completion of a…
Read More

Paris-based Exeliom Biosciences, a clinical-stage BioTech company developing new therapies in immuno-oncology and immuno-inflammation, today announced the completion of a…
Read More
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021…
Read More